Bausch Health Companies Inc. Restructuring Charges
Bausch Health Companies Inc. (BHC) reported Restructuring Charges of $9.00 million for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2021-08-03
- Bausch Health Companies Inc. restructuring charges for the quarter ending 2021-06-30 was $9.00M, a 28.57% increase year-over-year.
- Bausch Health Companies Inc. restructuring charges for the quarter ending 2021-03-31 was $12.00M, a 200.00% increase year-over-year.
- Bausch Health Companies Inc. restructuring charges for the quarter ending 2020-12-31 was $9.00M, a 200.00% increase year-over-year.
- Bausch Health Companies Inc. restructuring charges for the quarter ending 2020-09-30 was $2.00M, a 50.00% decline year-over-year.
- Bausch Health Companies Inc. restructuring charges for fiscal 2017 was $52.00M, a 60.61% decline from fiscal 2016.
- Bausch Health Companies Inc. restructuring charges for fiscal 2016 was $132.00M.
- Bausch Health Companies Inc. restructuring charges for fiscal 2014 was $382.00M, a 17.32% decline from fiscal 2013.
- Bausch Health Companies Inc. restructuring charges for fiscal 2013 was $462.00M, a 72.97% increase from fiscal 2012.
| Period end | Restructuring Charges 3 month | Restructuring Charges 3 month as first filed | Restructuring Charges 6 month | Restructuring Charges 6 month as first filed | Restructuring Charges 9 month | Restructuring Charges 9 month as first filed | Restructuring Charges 12 month | Restructuring Charges 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-06-30 | $9.00M 10-Q · filed 2021-08-03 | $21.00M 10-Q · filed 2021-08-03 | $30.00M derived: sum of 3 quarters · filed 2021-08-03 | $32.00M derived: sum of 4 quarters · filed 2021-08-03 | ||||
| 2021-03-31 | $12.00M 10-Q · filed 2021-05-04 | $21.00M derived: sum of 2 quarters · filed 2021-05-04 | $23.00M derived: sum of 3 quarters · filed 2021-05-04 | $30.00M derived: sum of 4 quarters · filed 2021-08-03 | ||||
| 2020-12-31 | $9.00M derived: 8-K 12 month − 10-Q 9 month · filed 2021-05-04 | $11.00M derived: sum of 2 quarters · filed 2021-05-04 | $18.00M derived: sum of 3 quarters · filed 2021-08-03 | $22.00M 8-K · filed 2021-05-04 | ||||
| 2020-09-30 | $2.00M 10-Q · filed 2020-11-03 | $9.00M derived: sum of 2 quarters · filed 2021-08-03 | $13.00M 10-Q · filed 2020-11-03 | $16.00M derived: sum of 4 quarters · filed 2021-08-03 | ||||
| 2020-06-30 | $7.00M 10-Q · filed 2021-08-03 | $11.00M 10-Q · filed 2021-08-03 | $14.00M derived: sum of 3 quarters · filed 2021-08-03 | $18.00M derived: sum of 4 quarters · filed 2021-08-03 | ||||
| 2020-03-31 | $4.00M 10-Q · filed 2021-05-04 | $7.00M derived: sum of 2 quarters · filed 2021-05-04 | $11.00M derived: sum of 3 quarters · filed 2021-05-04 | $15.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-12-31 | $3.00M derived: 8-K 12 month − 10-Q 9 month · filed 2021-05-04 | $7.00M derived: sum of 2 quarters · filed 2021-05-04 | $11.00M derived: sum of 3 quarters · filed 2021-05-04 | $31.00M 8-K · filed 2021-05-04 | ||||
| 2019-09-30 | $4.00M 10-Q · filed 2020-11-03 | $8.00M derived: sum of 2 quarters · filed 2020-11-03 | $28.00M 10-Q · filed 2020-11-03 | $34.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-06-30 | $4.00M 10-Q · filed 2020-08-06 | $24.00M 10-Q · filed 2020-08-06 | $30.00M derived: sum of 3 quarters · filed 2021-05-04 | $33.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-03-31 | $20.00M 10-Q · filed 2020-05-07 | $26.00M derived: sum of 2 quarters · filed 2021-05-04 | $29.00M derived: sum of 3 quarters · filed 2021-05-04 | $36.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2018-12-31 | $6.00M derived: 8-K 12 month − 10-Q 9 month · filed 2021-05-04 | $9.00M derived: sum of 2 quarters · filed 2021-05-04 | $16.00M derived: sum of 3 quarters · filed 2021-05-04 | $22.00M 8-K · filed 2021-05-04 | ||||
| 2018-09-30 | $3.00M 10-Q · filed 2019-11-04 | $10.00M derived: sum of 2 quarters · filed 2019-11-04 | $16.00M 10-Q · filed 2019-11-04 | $26.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-06-30 | $7.00M 10-Q · filed 2019-08-06 | $13.00M 10-Q · filed 2019-08-06 | $23.00M derived: sum of 3 quarters · filed 2020-02-19 | $29.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-03-31 | $6.00M 10-Q · filed 2019-05-06 | $16.00M derived: sum of 2 quarters · filed 2020-02-19 | $22.00M derived: sum of 3 quarters · filed 2020-02-19 | $40.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2017-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $16.00M derived: sum of 2 quarters · filed 2020-02-19 | $34.00M derived: sum of 3 quarters · filed 2020-02-19 | $52.00M 10-K · filed 2020-02-19 | ||||
| 2017-09-30 | $6.00M 10-Q · filed 2018-11-06 | $24.00M derived: sum of 2 quarters · filed 2018-11-06 | $42.00M 10-Q · filed 2018-11-06 | $96.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-06-30 | $18.00M 10-Q · filed 2018-08-07 | $36.00M 10-Q · filed 2018-08-07 | $90.00M derived: sum of 3 quarters · filed 2019-02-20 | $110.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-03-31 | $18.00M 10-Q · filed 2018-05-08 | $72.00M derived: sum of 2 quarters · filed 2019-02-20 | $92.00M derived: sum of 3 quarters · filed 2019-02-20 | $112.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2016-12-31 | $54.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $74.00M derived: sum of 2 quarters · filed 2019-02-20 | $94.00M derived: sum of 3 quarters · filed 2019-02-20 | $132.00M 10-K · filed 2019-02-20 | ||||
| 2016-09-30 | $20.00M 10-Q · filed 2017-11-07 | $20.70M 10-Q · filed 2016-11-09 | $40.00M derived: sum of 2 quarters · filed 2017-11-07 | $78.00M 10-Q · filed 2017-11-07 | $78.20M 10-Q · filed 2016-11-09 | $166.00M derived: sum of 4 quarters · filed 2018-08-10 | ||
| 2016-06-30 | $20.00M 10-Q · filed 2017-08-08 | $19.50M 10-Q · filed 2016-08-09 | $58.00M 10-Q · filed 2017-08-08 | $57.50M 10-Q · filed 2016-08-09 | $146.00M derived: sum of 3 quarters · filed 2018-08-10 | $221.60M derived: sum of 4 quarters · filed 2018-08-10 | ||
| 2016-03-31 | $38.00M 10-Q · filed 2017-05-09 | $126.00M derived: sum of 2 quarters · filed 2018-08-10 | $201.60M derived: sum of 3 quarters · filed 2018-08-10 | $345.00M derived: sum of 4 quarters · filed 2018-08-10 | ||||
| 2015-12-31 | $88.00M derived: 8-K 12 month − 10-Q 9 month · filed 2018-08-10 | $163.60M derived: sum of 2 quarters · filed 2018-08-10 | $307.00M derived: sum of 3 quarters · filed 2018-08-10 | $362.00M 8-K · filed 2018-08-10 | $361.90M 10-K · filed 2016-04-29 | |||
| 2015-09-30 | $75.60M 10-Q · filed 2016-11-09 | $219.00M derived: sum of 2 quarters · filed 2016-11-09 | $274.00M 10-Q · filed 2016-11-09 | $318.60M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | $143.40M 10-Q · filed 2016-08-09 | $198.40M 10-Q · filed 2016-08-09 | $243.00M derived: sum of 3 quarters · filed 2017-03-01 | $304.70M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $55.00M 10-Q · filed 2016-06-07 | $99.60M derived: sum of 2 quarters · filed 2017-03-01 | $161.30M derived: sum of 3 quarters · filed 2017-03-01 | $303.40M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | $44.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $106.30M derived: sum of 2 quarters · filed 2017-03-01 | $248.40M derived: sum of 3 quarters · filed 2017-03-01 | $382.00M 10-K · filed 2017-03-01 | $381.70M 10-K · filed 2015-02-25 | |||
| 2014-09-30 | $61.70M 10-Q · filed 2015-10-26 | $203.80M derived: sum of 2 quarters · filed 2015-10-26 | $337.40M 10-Q · filed 2015-10-26 | $453.70M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-06-30 | $142.10M 10-Q · filed 2015-07-28 | $275.70M 10-Q · filed 2015-07-28 | $392.00M derived: sum of 3 quarters · filed 2016-04-29 | $635.10M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-03-31 | $133.60M 10-Q · filed 2015-04-30 | $249.90M derived: sum of 2 quarters · filed 2016-04-29 | $493.00M derived: sum of 3 quarters · filed 2016-04-29 | $546.60M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2013-12-31 | $116.30M derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | $359.40M derived: sum of 2 quarters · filed 2016-04-29 | $413.00M derived: sum of 3 quarters · filed 2016-04-29 | $462.00M 10-K · filed 2016-04-29 | $514.83M 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $243.10M 10-Q · filed 2014-10-24 | $295.89M 10-Q · filed 2013-11-01 | $296.70M derived: sum of 2 quarters · filed 2014-10-24 | $345.70M 10-Q · filed 2014-10-24 | $398.54M 10-Q · filed 2013-11-01 | $477.59M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-06-30 | $53.60M 10-Q · filed 2014-08-01 | $53.66M 10-Q · filed 2013-08-07 | $102.60M 10-Q · filed 2014-08-01 | $102.65M 10-Q · filed 2013-08-07 | $234.49M derived: sum of 3 quarters · filed 2015-02-25 | $277.36M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-03-31 | $49.00M 10-Q · filed 2014-05-09 | $48.98M 10-Q · filed 2013-05-03 | $180.89M derived: sum of 2 quarters · filed 2015-02-25 | $223.76M derived: sum of 3 quarters · filed 2015-02-25 | $253.76M derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2012-12-31 | $131.89M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $174.76M derived: sum of 2 quarters · filed 2015-02-25 | $204.76M derived: sum of 3 quarters · filed 2015-02-25 | $267.10M 10-K · filed 2015-02-25 | $344.39M 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $42.87M 10-Q · filed 2013-11-01 | $72.88M derived: sum of 2 quarters · filed 2013-11-01 | $135.21M 10-Q · filed 2013-11-01 | $171.84M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-06-30 | $30.00M 10-Q · filed 2013-08-07 | $92.34M 10-Q · filed 2013-08-07 | $128.97M derived: sum of 3 quarters · filed 2014-02-28 | $144.84M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-03-31 | $62.34M 10-Q · filed 2013-05-03 | $98.97M derived: sum of 2 quarters · filed 2014-02-28 | $114.84M derived: sum of 3 quarters · filed 2014-02-28 | $142.47M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | $36.63M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $52.50M derived: sum of 2 quarters · filed 2014-02-28 | $80.13M derived: sum of 3 quarters · filed 2014-02-28 | $97.67M 10-K · filed 2014-02-28 | ||||
| 2011-09-30 | $15.87M 10-Q · filed 2012-11-05 | $43.50M derived: sum of 2 quarters · filed 2012-11-05 | $61.04M 10-Q · filed 2012-11-05 | $102.47M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | $27.63M 10-Q · filed 2012-08-03 | $45.16M 10-Q · filed 2012-08-03 | $86.59M derived: sum of 3 quarters · filed 2013-02-28 | $182.51M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $17.54M 10-Q · filed 2012-05-04 | $58.97M derived: sum of 2 quarters · filed 2013-02-28 | $154.88M derived: sum of 3 quarters · filed 2013-02-28 | $157.77M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $41.43M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $137.35M derived: sum of 2 quarters · filed 2013-02-28 | $140.23M derived: sum of 3 quarters · filed 2013-02-28 | $140.84M 10-K · filed 2013-02-28 | ||||
| 2010-09-30 | $95.92M 10-Q · filed 2011-11-04 | $98.80M derived: sum of 2 quarters · filed 2011-11-04 | $99.41M 10-Q · filed 2011-11-04 | $114.31M derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2010-06-30 | $2.88M 10-Q · filed 2011-08-08 | $3.49M 10-Q · filed 2011-08-08 | $18.40M derived: sum of 3 quarters · filed 2012-02-29 | $20.81M derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2010-03-31 | $613.00K 10-Q · filed 2011-05-10 | $15.52M derived: sum of 2 quarters · filed 2012-02-29 | $17.93M derived: sum of 3 quarters · filed 2012-02-29 | $29.30M derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2009-12-31 | $14.90M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $17.32M derived: sum of 2 quarters · filed 2012-02-29 | $28.68M derived: sum of 3 quarters · filed 2012-02-29 | $30.03M 10-K · filed 2012-02-29 | ||||
| 2009-09-30 | $2.41M 10-Q · filed 2010-11-05 | $13.78M derived: sum of 2 quarters · filed 2010-11-05 | $15.13M 10-Q · filed 2010-11-05 | |||||
| 2009-06-30 | $11.37M 10-Q · filed 2010-08-06 | $12.71M 10-Q · filed 2010-08-06 | ||||||
| 2008-12-31 | $70.20M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |